Association of Micropapillary Architecture and High Tumor Budding with Prognosis in Patients with Stage III Colon Cancer from a FOLFOX-Based Adjuvant Chemotherapy Trial: NCCTG N0147 (Alliance)

Authors

Suresh G. Nair MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2017

Volume

97

Published In/Presented At

Gastrointestinal Pathology. Lab Invest 97 (Suppl 1), 157–210 (2017). https://doi.org/10.1038/labinvest.2016.168

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article